These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3523470)

  • 1. Human insulin. Its development and clinical use.
    Ahrens ER; Gossain VV; Rovner DR
    Postgrad Med; 1986 Jul; 80(1):181-4, 187. PubMed ID: 3523470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of highly purified Iletin-II-type porcine insulins and human insulin preparations in clinical practice].
    Petunina NA; Balabolkin MI; Mkrtumian AM; Sergeev AV; Nedosugova LV
    Ter Arkh; 1993; 65(10):29-31. PubMed ID: 8296229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus.
    Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH
    Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK diabetics plan insulin suit.
    Cherfas J
    Science; 1991 Sep; 253(5024):1090. PubMed ID: 1887235
    [No Abstract]   [Full Text] [Related]  

  • 8. The therapeutic efficacy of human insulin (recombinant DNA) in patients with insulin-dependent diabetes mellitus: a comparative study with purified porcine insulin.
    Howey DC; Fineberg SE; Nolen PA; Stone MI; Gibson RG; Fineberg NS; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():73-7. PubMed ID: 6765546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and allergenic potential of animal and human insulins.
    Schernthaner G
    Diabetes Care; 1993 Dec; 16 Suppl 3():155-65. PubMed ID: 8299472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA).
    Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ
    Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trying times for human insulin.
    Wolff SP
    Nature; 1992 Apr; 356(6368):375-6. PubMed ID: 1445519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human insulin (recombinant DNA) in the treatment of patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM).
    Lotz N; Bachmann W; Mehnert H
    Diabetes Care; 1982; 5 Suppl 2():149-51. PubMed ID: 6765527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
    Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin therapy in the last decade. A pediatric perspective.
    Santiago JV
    Diabetes Care; 1993 Dec; 16 Suppl 3():143-54. PubMed ID: 8299471
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insulins and new ways with insulin.
    Devlin J
    Ir Med J; 1982 Sep; 75(9):344-6. PubMed ID: 6754658
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study.
    Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R
    Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1987 Sep; 34(3):350-71. PubMed ID: 3315622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.